Pall Will Seek To Aid FDA In U.S. Leukocyte Filtration Initiatives
This article was originally published in The Gray Sheet
Executive Summary
Pall Corporation will aid FDA through broad-scale programs in implementing routine leukocyte filtration of the U.S. blood supply, the company says.